Doctors Note Logo

Published on: 4/29/2026

How PRP for Macular Degeneration Works? Why Your Vision Is Fading & Next Steps

Platelet-rich plasma therapy uses your own blood’s concentrated platelets to deliver growth factors that can stimulate retinal cell repair, protect photoreceptors and reduce inflammation in both dry and wet age-related macular degeneration. This minimally invasive treatment may slow vision loss, improve visual acuity and contrast sensitivity, and even delay the need for other interventions.

There are several important factors to consider, from risks such as transient pressure increases or inflammation to lifestyle changes, monitoring and combined therapies; see below for complete details on benefits, risks and next steps.

answer background

Explanation

How PRP for Macular Degeneration Works

Why Your Vision Is Fading & Next Steps

Age-related macular degeneration (AMD) affects millions worldwide, gradually stealing central vision used for reading, driving and recognizing faces. Platelet-rich plasma (PRP) therapy is emerging as a promising approach to slow or even partially reverse retinal damage. Below is a clear, step-by-step look at how PRP for macular degeneration works, why your vision may be fading, and what you can do next.


Understanding Macular Degeneration

The macula sits at the center of your retina and is responsible for sharp, detailed vision. When it deteriorates, you may notice:

  • Blurred or wavy central vision
  • Difficulty reading small print
  • Fading or blank spots in your center field of view

There are two main types:

  • Dry AMD – Characterized by thinning macular tissue and drusen (tiny protein deposits).
  • Wet AMD – Involves abnormal blood vessel growth under the retina, which can leak fluid or blood.

Early detection is vital. If you're experiencing any of these warning signs, you can quickly assess your symptoms with a free Age-Related Macular Degeneration symptom checker to help determine your next steps.


What Is PRP Therapy?

Platelet-rich plasma (PRP) is a concentrate of platelets derived from your own blood. Platelets contain growth factors and proteins that support tissue repair and reduce inflammation. In ophthalmology, PRP can be repurposed to:

  1. Stimulate retinal cell repair
  2. Protect existing photoreceptors
  3. Modulate inflammation

Because PRP is autologous (from your own body), it carries minimal risk of allergic reaction.


How PRP for Macular Degeneration Works

  1. Blood Draw
    • A small sample of blood (15–30 mL) is taken from your arm.
  2. Centrifugation
    • The sample is spun in a centrifuge to separate red cells from plasma.
    • The plasma layer, rich in platelets, is carefully collected.
  3. Activation
    • Platelets are "activated" with calcium or thrombin to release growth factors.
  4. Injection
    • Under local anesthesia, a fine needle delivers PRP into the vitreous cavity (the gel inside your eye) or just beneath the retina, depending on the protocol.
  5. Growth Factor Release
    • Over days to weeks, PRP releases molecules such as PDGF, VEGF-A modulators, TGF-β and EGF, which:
    • Encourage repair of retinal pigment epithelial (RPE) cells
    • Protect photoreceptors from further damage
    • Reduce local inflammation and oxidative stress

Why Your Vision Is Fading

Macular degeneration progresses because of:

  • Oxidative stress – Free radicals damage delicate retinal cells.
  • RPE dysfunction – The "support cells" that nourish photoreceptors become compromised.
  • Drusen buildup – Waste materials accumulate, disrupting retinal metabolism.
  • Neovascularization (in wet AMD) – Fragile new vessels leak and scar the macula.

PRP aims to counteract these processes by supplying concentrated growth factors and anti-inflammatory proteins right where they're needed.


Potential Benefits of PRP Therapy

Early clinical studies and case reports suggest that PRP for macular degeneration may:

  • Slow the progression of both dry and wet AMD
  • Improve visual acuity in some patients
  • Enhance contrast sensitivity (the ability to distinguish shades)
  • Reduce inflammation and drusen size
  • Delay the need for repeated anti-VEGF injections in wet AMD

Possible Risks & Side Effects

While generally well-tolerated, PRP injections carry some risks:

  • Transient increase in intraocular pressure
  • Mild inflammation (iritis or vitritis)
  • Rare infection inside the eye (endophthalmitis)
  • Floaters or mild eye discomfort

Your eye surgeon will discuss these risks and monitor you closely after treatment.


Next Steps: What You Can Do Now

  1. Consult a Retina Specialist
    • Discuss whether PRP therapy or other treatments (anti-VEGF, photodynamic therapy) suit your type of AMD.
  2. Lifestyle Adjustments
    • Follow a nutrient-rich diet (leafy greens, omega-3 fatty acids).
    • Quit smoking and manage blood pressure.
  3. Supplements
    • AREDS2 formula vitamins may slow progression in intermediate AMD.
  4. Regular Monitoring
    • Get OCT (optical coherence tomography) scans and Amsler grid checks at home.
  5. Second Opinions & Clinical Trials
    • Ask about ongoing PRP clinical trials or combined therapies.

If you're noticing changes in your vision but aren't sure whether they warrant medical attention, take a few minutes to complete a confidential Age-Related Macular Degeneration symptom assessment powered by AI technology.


Final Thoughts

PRP for macular degeneration is an exciting frontier that leverages your body's own healing mechanisms. While not a cure, it may slow vision loss and, in some cases, improve sight. Talk openly with your eye doctor about benefits, risks and other available therapies. Early intervention is your best defense against central vision decline.

Disclaimer: This information is for educational purposes and does not replace professional medical advice. Always speak to a qualified healthcare provider about any vision changes or serious health concerns. If you experience sudden vision loss, severe eye pain or other alarming symptoms, seek immediate medical attention.

(References)

  • * Bakir B, Ozkagnici A, Gundogdu A. Platelet-Rich Plasma for Retinal and Optic Nerve Diseases: A Review of Clinical Efficacy and Basic Science. J Ocul Pharmacol Ther. 2022 Sep;38(7):437-446. doi: 10.1089/jop.2021.0125. Epub 2022 Aug 23. PMID: 36014443.

  • * Wang Y, Zhang X, Zhou H. Molecular mechanisms of platelet-rich plasma in ocular diseases: a systematic review. Regen Med. 2022 Aug;17(8):613-625. doi: 10.2217/rme-2021-0205. Epub 2022 May 25. PMID: 35624796.

  • * Cokkinos DD, Tsilimbaris MK, Kontadakis GA, Glynos AI, Charakidou A, Cokkinos DG. Platelet-Rich Plasma in the Treatment of Age-Related Macular Degeneration: A Systematic Review. Adv Ophthalmol. 2020 Feb 24;2020:6458514. doi: 10.1155/2020/6458514. PMID: 32095315; PMCID: PMC7058864.

  • * Pappa C, Kapetanios AD, Panagiotakopoulos KP, Zouridaki G, Tsakalakis V, Vlachos DE. Mechanisms of action of platelet-rich plasma in the treatment of age-related macular degeneration. Ther Adv Ophthalmol. 2020 Oct 19;12:2515841420967398. doi: 10.1177/2515841420967398. PMID: 33100224; PMCID: PMC7576922.

  • * Bakri SJ, Singh R, Han DP, Sheth BP, Sharma A, Kim JE, Iezzi R, Mittra R. Autologous Platelet-Rich Plasma as an Adjunctive Treatment in Neovascular Age-Related Macular Degeneration. Ophthalmic Surg Lasers Imaging Retina. 2016 Aug 1;47(8):724-31. doi: 10.3928/23258160-20160802-05. PMID: 27529681.

Thinking about asking ChatGPT?Ask me instead

Tell your friends about us.

We would love to help them too.

smily Shiba-inu looking

For First Time Users

What is Ubie’s Doctor’s Note?

We provide a database of explanations from real doctors on a range of medical topics. Get started by exploring our library of questions and topics you want to learn more about.

Was this page helpful?

Purpose and positioning of servicesUbie Doctor's Note is a service for informational purposes. The provision of information by physicians, medical professionals, etc. is not a medical treatment. If medical treatment is required, please consult your doctor or medical institution. We strive to provide reliable and accurate information, but we do not guarantee the completeness of the content. If you find any errors in the information, please contact us.